112 related articles for article (PubMed ID: 7330508)
1. [Physicochemical basis for the formation of calcium oxalate renal stones. Estimation of the degree of urine saturation with the activity product ratio (CPA) (author's transl)].
Peña JC; Fishleder S; Galván P; Herrera-Acosta J
Rev Invest Clin; 1981; 33(4):333-41. PubMed ID: 7330508
[No Abstract] [Full Text] [Related]
2. The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment.
Peña JC; Monforte MF; Briceño A
J Urol; 1987 Nov; 138(5):1137-40. PubMed ID: 3669156
[TBL] [Abstract][Full Text] [Related]
3. Comparison of semi-empirical and computer derived methods for estimating urinary saturation of calcium oxalate.
Pak CY; Maalouf NM; Rodgers K; Poindexter JR
J Urol; 2009 Dec; 182(6):2951-6. PubMed ID: 19846163
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical basis for formation of renal stones of calcium phosphate origin: calculation of the degree of saturation of urine with respect to brushite.
Pak CY
J Clin Invest; 1969 Oct; 48(10):1914-22. PubMed ID: 5822595
[TBL] [Abstract][Full Text] [Related]
5. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
[TBL] [Abstract][Full Text] [Related]
6. Effect of amiloride with or without hydrochlorothiazide on urinary calcium and saturation of calcium salts.
Leppla D; Browne R; Hill K; Pak CY
J Clin Endocrinol Metab; 1983 Nov; 57(5):920-4. PubMed ID: 6619267
[TBL] [Abstract][Full Text] [Related]
7. [Calcium oxalate activity products and discriminant analysis of urinary parameters as basis for a calcium oxalate screening program (author's transl)].
Brundig P; Berg W; Naumann J; Hoppe H; Cumme GA; Achilles W; Schneider HJ
Urologe A; 1980 Jan; 19(1):54-6. PubMed ID: 7355530
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of oxalate concentration in serum and urine of children with renal stones].
Jadeszko I; Porowski T; Zoch-Zwierz WM; Wasilewska AM; Hackiewicz L
Wiad Lek; 2005; 58 Suppl 1():20-4. PubMed ID: 16060079
[TBL] [Abstract][Full Text] [Related]
9. Assessment of urine saturation and inhibitory index in patients with calcium oxalate kidney stone and normals.
Sun CT; Cao LC; Han KH
Chin Med J (Engl); 1987 Dec; 100(12):935-9. PubMed ID: 3133165
[No Abstract] [Full Text] [Related]
10. [Degree of saturation of urine with calcium oxalate in patients with metabolically active calcium-oxalate urolithiasis].
Głuszek J; Raszeja-Wanic B; Pupek-Musialik D; Luzna B
Pol Tyg Lek; 1979 Nov; 34(46):1777-9. PubMed ID: 575672
[No Abstract] [Full Text] [Related]
11. Ion binding by small molecular weight substances (1,000-10,000 daltons) in urine.
Nicar MJ; Holt K; Pak CY
Invest Urol; 1980 Sep; 18(2):162-4. PubMed ID: 7410030
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the state of saturation of brushite and calcium oxalate in urine: a comparison of three methods.
Pak CY; Hayashi Y; Finlayson B; Chu S
J Lab Clin Med; 1977 Apr; 89(4):891-901. PubMed ID: 845489
[TBL] [Abstract][Full Text] [Related]
13. Rapid Communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate.
Pak CY; Adams-Huet B; Poindexter JR; Pearle MS; Peterson RD; Moe OW
Kidney Int; 2004 Nov; 66(5):2032-7. PubMed ID: 15496176
[TBL] [Abstract][Full Text] [Related]
14. Effect of hydrochlorothiazide on renal hypercalciuria.
Voskaki I; al Qadreh A; Mengreli C; Sbyrakis S
Child Nephrol Urol; 1992; 12(1):6-9. PubMed ID: 1606587
[TBL] [Abstract][Full Text] [Related]
15. Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine.
Woelfel A; Kaplan RA; Pak CY
Metabolism; 1977 Feb; 26(2):201-5. PubMed ID: 834153
[TBL] [Abstract][Full Text] [Related]
16. [Compared metabolic effects of phosphorus or hydrochlorothiazide therapy in hypercalciuric stone-formers (author's transl)].
Dard S; Ulmann A
Nephrologie; 1981; 2(1):4-7. PubMed ID: 7345375
[TBL] [Abstract][Full Text] [Related]
17. Urinary saturation measurements in calcium nephrolithiasis.
Weber DV; Coe FL; Parks JH; Dunn MS; Tembe V
Ann Intern Med; 1979 Feb; 90(2):180-4. PubMed ID: 443649
[TBL] [Abstract][Full Text] [Related]
18. Crystallization properties in urine from calcium oxalate stone formers.
Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the physicochemical risk for renal stone disease during pregnancy.
Smith CL; Kristensen C; Davis M; Abraham PA
Clin Nephrol; 2001 Mar; 55(3):205-11. PubMed ID: 11316240
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous nucleation of calcium oxalate crystals in mammalian urine.
Khan SR
Scanning Microsc; 1995 Jun; 9(2):597-614; discussion 614-6. PubMed ID: 8714752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
